The G7 system is now available in the U.K., Ireland, Germany, Austria and Hong Kong. Dexcom said it plans to reach outlets in South Africa and New Zealand in the weeks ahead and additional countries ...

After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...

Dexcom said it is working with insulin pump manufacturers to integrate its new G7 sensor into current and future automated artificial pancreas systems. (Dexcom) Dexcom has obtained European approval ...

苏格兰爱丁堡和圣地亚哥--(BUSINESS WIRE)--(美国商业资讯)-- (美国商业资讯)--糖尿病患者实时连续血糖监测领域的全球领导者DexCom, Inc.(NASDAQ:DXCM)今天宣布，其Dexcom G7连续血糖监测(CGM)系统已获得CE认证(Conformité Européenne)，适用于欧洲两岁及以上的糖尿病患者，包括孕妇 ...

This combined sensor-transmitter continuous glucose monitor (CGM) technology offers glucose values every 5 minutes. Sensors last for up to 10-15 days and provide alerts for high and low blood sugars ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

Continuous glucose monitoring (CGM) tracks glucose levels every 1 to 5 minutes, helping people with diabetes understand how food, sleep, and exercise affect their blood sugar without frequent ...

Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...

The Dexcom G7 continuous glucose monitor (CGM) is as accurate or better than other currently marketed CGM devices for measuring glucose in those with diabetes, new data from a pivotal study suggest.